Manasa Kumar Panda
Research Subjects
Manasa Kumar Panda has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Yengkhom Disco Singh
Department of Post-Harvest Technology, College of Horticulture and Forestry, Central Agricultural University, Pasighat, India
3 shared publications - Punuri Jayasekhar Babu
Biomaterials and Bioengineering Research Laboratory, Department of Biotechnology, Mizoram University, Pachhunga University College Campus, Aizawl, India
2 shared publications Rina Ningthoujam
Central Agricultural University
2 shared publicationsAvanindra Kumar Mishra
Deputy Director of Research, Central Agricultural University, Imphal, 7 95004, Manipur, India
1 shared publicationBarsarani Jena
Department of Botany, School of Applied Sciences, Centurion University of Technology and Management, Bhubaneswar, 752050, Odisha, India
1 shared publication- Bimal Prasad Jit
School of Life Sciences, Sambalpur University, Burla, Sambalpur, Odisha-768019. India
1 shared publication
Latest Publications
- 2 March 2022
- Published by Springer Nature
- p. 217-232
Predicting Biomarkers and Therapeutic Targets in Cancer
- 2 March 2022
- Published by Springer Nature
- p. 217-232
Predicting Biomarkers and Therapeutic Targets in Cancer
- Open Access
- 1 January 2021
- Published by KEAI Publishing in Sensors International
- Vol. 2, 100099
Insight from nanomaterials and nanotechnology towards COVID-19
The pandemic disease coronavirus disease 2019 (covid-19) becomes one of the most dreaded disease in the history of mankind in the entire world. The covid-19 outbreak started from Wuhan city of China and then rapidly transmitted throughout the world causing mass destruction and seldom. This sporadical disease has taken many lives due to sudden outbreak and no particular vaccines were available at the early waves. All the vaccines developed are mostly targeted to spike protein of the virus and there is encapsulation of mRNA and nanoparticles. Nanotechnology intervention in the fighting against the covid-19 is one way to tackle the disease from different angle including nano coating mask, nano diagnostic kits, nano sanitizer, and nano medicine. This article highlights the intervention of nanotechnology and its possible treatment against the covid-19. It is high time to come together all the units of material science and biological science to fight against the dreaded covid-19. As an alternative strategy, a multidisciplinary research effort, consisting of classical epidemiology and clinical methodologies, drugs and nanotechnology, engineering science and biological apprehension, can be adopted for developing improved drugs exhibiting antivirals activities. Nanotechnology can be explored to detect, treat, and prevent the covid-19 disease.
- 1 January 2021
- Published by KEAI Publishing in Sensors International
- Vol. 2, 100099
Open AccessInsight from nanomaterials and nanotechnology towards COVID-19
The pandemic disease coronavirus disease 2019 (covid-19) becomes one of the most dreaded disease in the history of mankind in the entire world. The covid-19 outbreak started from Wuhan city of China and then rapidly transmitted throughout the world causing mass destruction and seldom. This sporadical disease has taken many lives due to sudden outbreak and no particular vaccines were available at the early waves. All the vaccines developed are mostly targeted to spike protein of the virus and there is encapsulation of mRNA and nanoparticles. Nanotechnology intervention in the fighting against the covid-19 is one way to tackle the disease from different angle including nano coating mask, nano diagnostic kits, nano sanitizer, and nano medicine. This article highlights the intervention of nanotechnology and its possible treatment against the covid-19. It is high time to come together all the units of material science and biological science to fight against the dreaded covid-19. As an alternative strategy, a multidisciplinary research effort, consisting of classical epidemiology and clinical methodologies, drugs and nanotechnology, engineering science and biological apprehension, can be adopted for developing improved drugs exhibiting antivirals activities. Nanotechnology can be explored to detect, treat, and prevent the covid-19 disease.
- 7 December 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 21 (14) , 1412-1421
Bioactive Molecules from the Alpinia Genus: A Comprehensive Review
Background: Floral has diversity and unique nature due to the complex structure and component. Alpinia is an important genus of the Zingiberaceae family having complex taxonomical diversity. The presence of many unique bioactive molecules makes this genus, a pharmaceutically important genus. They provide a wide range of medicinal properties, including traditional remedies to modern therapeutic applications. Methods: Extracts of Alpinia mostly contain bioactive molecules and secondary metabolites such as polyphenolics, tannins, flavonoids and other therapeutically important compounds. These bioactive molecules are biologically active, treating against inflammation, cancer, arterial hypertension, and other deadly diseases. Results: These bioactive molecules can act as natural enzyme inhibitors for some of the deadly diseases and can block the pathway for metabolic activities. In addition, these genera have played a major role in multidisciplinary studies of phytochemistry, ethnobotany, and pharmacological aspects in day-to-day life. Conclusion: Therefore, this review highlights the fewer known facts of the genus Alpinia in terms of bioactive molecules and its significant therapeutic applications to help in combating major diseases of humans.
- 7 December 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 21 (14) , 1412-1421
Bioactive Molecules from the Alpinia Genus: A Comprehensive Review
Background: Floral has diversity and unique nature due to the complex structure and component. Alpinia is an important genus of the Zingiberaceae family having complex taxonomical diversity. The presence of many unique bioactive molecules makes this genus, a pharmaceutically important genus. They provide a wide range of medicinal properties, including traditional remedies to modern therapeutic applications. Methods: Extracts of Alpinia mostly contain bioactive molecules and secondary metabolites such as polyphenolics, tannins, flavonoids and other therapeutically important compounds. These bioactive molecules are biologically active, treating against inflammation, cancer, arterial hypertension, and other deadly diseases. Results: These bioactive molecules can act as natural enzyme inhibitors for some of the deadly diseases and can block the pathway for metabolic activities. In addition, these genera have played a major role in multidisciplinary studies of phytochemistry, ethnobotany, and pharmacological aspects in day-to-day life. Conclusion: Therefore, this review highlights the fewer known facts of the genus Alpinia in terms of bioactive molecules and its significant therapeutic applications to help in combating major diseases of humans.